Evidence map›Paper›PMID 32755474›Full record

ArticleHuman vaccines & immunotherapeutics2021

TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines.

Irene Rivero-Calle, Jose Gómez-Rial, Louis Bont, Bradford D Gessner, Melvin Kohn, Ron Dagan, Daniel C Payne, Laia Bruni, Andrew J Pollard, Adolfo García-Sastre and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Irene Rivero-CalleTranslational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario De Santiago De Compostela, Santiago De Compostela, Spain.ORCID 0000-0002-3678-9264
Jose Gómez-RialGenetics, Vaccines and Infections Research Group (GENVIP), Instituto De Investigación Sanitaria De Santiago, Universidad De Santiago De Compostela, Santiago De Compostela, Spain.
Louis BontWilhelmina's Children's Hospital University Medical Center Utrecht, The Netherlands.
Bradford D GessnerPfizer Vaccines, Collegeville, PA, USA.
Melvin KohnVaccines and Infectious Diseases Medical Affairs, Global Medical and Scientific Affairs, Merck & Co. Inc., Kenilworth, NJ, USA.
Ron DaganThe Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.ORCID 0000-0002-8888-1046
Daniel C PayneDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Laia BruniCancer Epidemiology Research Program, Institut Català d'Oncologia (ICO) - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
Andrew J PollardOxford Vaccines Group, Department of Paediatrics, University of Oxford and the NIHR Oxford Biomedical Research Centre, Oxford, UK.
Adolfo García-SastreDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Denise L FaustmanThe Immunobiology Laboratory, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Albert OsterhausArtemis One Health, Utrecht, The Netherlands.
Robb ButlerWHO Regional Office for Europe, Copenhagen, Denmark.
Francisco Giménez SánchezBalmis Vaccine Institute, Almería, Spain.
Francisco ÁlvarezCommittee on Vaccine Advisory [CAV-AEP], Spain.
Myrsini KaforouDepartment of Infectious Disease, Imperial College London, London, UK.
Xabier BelloGenetics, Vaccines and Infections Research Group (GENVIP), Instituto De Investigación Sanitaria De Santiago, Universidad De Santiago De Compostela, Santiago De Compostela, Spain.ORCID 0000-0002-4990-8496
Federico Martinón-TorresTranslational Paediatrics and Infectious Diseases, Department of Paediatrics, Hospital Clínico Universitario De Santiago De Compostela, Santiago De Compostela, Spain.ORCID 0000-0002-9023-581X

Funding

World Health Organization 001
6 · The paper itself

Abstract

TIPICO is an expert meeting and workshop that aims to provide the most recent evidence in the field of infectious diseases and vaccination. The 10th Interactive Infectious Disease TIPICO workshop took place in Santiago de Compostela, Spain, on November 21-22, 2019. Cutting-edge advances in vaccination against respiratory syncytial virus,

Indexed as

Communicable DiseasesRespiratory Syncytial Virus, HumanAnimalsBCG VaccineHumansSpainVaccinationBCG Vaccinebig dataemergent virusInfectious diseaseoff-target effectsRNA gene signaturestranscriptomicsvaccine hesitancyvaccine-preventable diseasesvaccine resiliencezoonoses

Identifiers

PMID32755474
PMCPMC7996078

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.